NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,956,000 | +6.1% | 22,512 | +11.5% | 0.06% | +5.2% |
| Q2 2019 | $1,843,000 | +99.0% | 20,188 | +109.6% | 0.06% | +93.3% |
| Q1 2019 | $926,000 | +51.1% | 9,632 | +34.9% | 0.03% | +30.4% |
| Q4 2018 | $613,000 | -64.5% | 7,140 | -64.3% | 0.02% | -56.6% |
| Q3 2018 | $1,725,000 | +20.6% | 20,020 | +5.8% | 0.05% | +15.2% |
| Q2 2018 | $1,430,000 | +5.6% | 18,928 | +13.0% | 0.05% | +2.2% |
| Q1 2018 | $1,354,000 | +8.7% | 16,744 | +12.8% | 0.04% | +7.1% |
| Q4 2017 | $1,246,000 | -2.2% | 14,840 | 0.0% | 0.04% | -8.7% |
| Q3 2017 | $1,274,000 | +2.8% | 14,840 | 0.0% | 0.05% | +2.2% |
| Q2 2017 | $1,239,000 | +12.4% | 14,840 | 0.0% | 0.04% | +7.1% |
| Q1 2017 | $1,102,000 | +1.9% | 14,840 | 0.0% | 0.04% | -10.6% |
| Q4 2016 | $1,081,000 | – | 14,840 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |